Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene

scientific article published in June 1998

Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ANA.410430604
P698PubMed publication ID9629839

P50authorE. Tessa Hedley-WhyteQ120721373
P2093author name stringChen C
Cudkowicz ME
Brown RH Jr
McKenna-Yasek D
P2860cites workMutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisQ28131805
Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosisQ28303406
Superoxide dismutase in familial amyotrophic lateral sclerosis: models for gain of functionQ41111012
Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene: pathological and immunocytochemical changesQ41187994
An update on superoxide dismutase 1 in familial amyotrophic lateral sclerosisQ41194811
Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in ScandinaviaQ48596448
P433issue6
P921main subjectcopperQ753
amyotrophic lateral sclerosisQ206901
P304page(s)703-710
P577publication date1998-06-01
P1433published inAnnals of NeurologyQ564414
P1476titleLimited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene
P478volume43

Reverse relations

cites work (P2860)
Q35726226Aberrant neuregulin 1 signaling in amyotrophic lateral sclerosis
Q58152648Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosis
Q40957607Accrued somatic mutations (nucleic acid changes) trigger ALS: 2005-2015 update
Q33839535Amyotrophic lateral sclerosis: copper/zinc superoxide dismutase (SOD1) gene mutations
Q50902208An autopsy case of sporadic amyotrophic lateral sclerosis associated with the I113T SOD1 mutation.
Q58181059An unusual case of familial ALS and cerebellar ataxia
Q48147320Autosomal dominant juvenile amyotrophic lateral sclerosis
Q33586412Carrell-Krusen Symposium invited lecture. Clinical trials in motor neuron diseases
Q82029139Chapter 5 Cytopathology of the motor neuron
Q73128584Clinical characteristics of SOD1 gene mutations in UK families with ALS
Q51718105Clinical features and neuropathological findings of familial amyotrophic lateral sclerosis with a His46Arg mutation in Cu/Zn superoxide dismutase.
Q37274526Clinical neurogenetics: amyotrophic lateral sclerosis
Q28198830Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS
Q37189268Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis
Q39710272Defining SOD1 ALS natural history to guide therapeutic clinical trial design
Q34983540Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex
Q36743954Diagnostic clues and more from photographs
Q48357421Differential expression of genes in amyotrophic lateral sclerosis revealed by profiling the post mortem cortex
Q54158931Familial Amyotrophic Lateral Sclerosis.
Q34547620Familial amyotrophic lateral sclerosis
Q45342245Familial amyotrophic lateral sclerosis with Cys111Tyr mutation in Cu/Zn superoxide dismutase showing widespread Lewy body-like hyaline inclusions
Q48611420Familial amyotrophic lateral sclerosis with an I104F mutation in the SOD1 gene: Multisystem degeneration with neurofilamentous aggregates and SOD1 inclusions
Q26741250From animal models to human disease: a genetic approach for personalized medicine in ALS
Q34479235Genetic overlap between apparently sporadic motor neuron diseases
Q34509807Genetically engineered models relevant to neurodegenerative disorders: their value for understanding disease mechanisms and designing/testing experimental therapeutics
Q51107457Genetics of Amyotrophic Lateral Sclerosis.
Q36573336Molecular biology of amyotrophic lateral sclerosis: insights from genetics
Q37959310Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology
Q89976497Mutations in Superoxide Dismutase 1 (Sod1) Linked to Familial Amyotrophic Lateral Sclerosis Can Disrupt High-Affinity Zinc-Binding Promoted by the Copper Chaperone for Sod1 (Ccs)
Q36181355Ongoing trials in motor neurone disease
Q21266563Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis
Q74297199Progressive muscular atrophy variant of familial amyotrophic lateral sclerosis (PMA/ALS)
Q33356197Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival
Q92106562Redox Regulation of the Microcirculation
Q44956628SOD1 gene mutations in ALS patients from British Columbia, Canada: clinical features, neurophysiology and ethical issues in management
Q34613895Study of 962 patients indicates progressive muscular atrophy is a form of ALS.
Q28246284Superoxyde dismutase 1 gene abnormalities in familial amyotrophic lateral sclerosis: phenotype/genotype correlations. The French experience and review of the literature
Q77892135The genetic and molecular mechanisms of motor neuron disease
Q38259758The phenotypic variability of amyotrophic lateral sclerosis